Back to
CAPSTONE INVESTMENT ADVISORS, LLC
AGNShowing 0 of 7 quarters
Position history for
CAPSTONE INVESTMENT ADVISORS, LLC's holdings in ALLERGAN PLC
As of its Q1 2020 13F, Capstone Investment Advisors held 91,010 shares of AGN (Allergan), worth $16.1M. Capstone Investment Advisors' 13F filings listed AGN from Q4 2018 to Q1 2020, 6 quarterly filings. AGN was 0.3% of Capstone Investment Advisors' reported 13F portfolio.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of AGN: STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C., FARALLON CAPITAL MANAGEMENT, L.L.C.